NCT05185518: Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes |
|
|
| Not yet recruiting | N/A | 18 | NA | Use of novel insulin injection port | Pacific Diabetes Technologies, Oregon Health and Science University | Type 2 Diabetes Treated With Insulin | 12/25 | 02/26 | | |